Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-11-057780)

Filing Details

Accession Number:: 0001104659-11-057780
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-10-25 21:55:41
Reporting Period:: 2011-10-21

Filing Date:: 2011-10-25
Accepted Time:: 2011-10-25 21:55:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1316175	Anthera Pharmaceuticals Inc	ANTH	Pharmaceutical Preparations (2834)	201852016

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1120362	F Paul Truex	C/O Anthera Pharmaceuticals, Inc. 25801 Industrial Blvd Suite B Hayward CA 94538	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-10-21	11,356	$6.25	649,004	No	4	S	Indirect	By Trust
Common Stock	Disposition	2011-10-21	11,879	$6.25	637,125	No	4	S	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	90,512	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 1, 2011.